RxDoctor Payments Data

Lisa Brooks

Family · Pinehurst, NCNPI 1609461656

Payments from drug & device makers

$588in general payments, 2019–2025

Across 32 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$135
  • Indivior Inc.$127
  • Braeburn Inc.$94
  • Valinor Pharma, LLC$60
  • Collegium Pharmaceutical, Inc.$36
  • Scilex Pharmaceuticals Inc.$36
  • plus $100 from 5 others

What the payments were for

  • Food & beverage$588100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$588 in reported general payments places this provider in the 60th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$49,448
Medicare patients
30
Services billed
451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl380$64,036
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen632$57,118
Xtampza ErOxycodone Myristate42$24,753
SuboxoneBuprenorphine Hcl/Naloxone Hcl45$24,197
MovantikNaloxegol Oxalate57$23,157
LinzessLinaclotide17$9,156
Gabapentin329$4,506
Buprenorphine23$3,737
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen61$3,160
Oxycodone Hcl138$2,420
Lidocaine25$2,372
Buprenorphine Hcl22$1,414
Tizanidine Hcl81$1,395
Cyclobenzaprine Hcl67$1,072
Pregabalin55$632

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine, Buprenorphine Hcl$27$69,187425 claims
Collegium Pharmaceutical, Inc.Xtampza Er$36$24,75342 claims
Indivior Inc.Suboxone$127$24,19745 claims
AbbVieLinzess$24$9,15617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,522 family providers in North Carolina.

Other family in Pinehurst

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →